MBQ Pharma

Funding and NIH signals

• SEC Form D raise Raised $991K (Form D filed Aug 14, 2026); +4 other Form D filings in the last 12 months. SEC Form D 0002148840-26-000005 (Aug 14, 2026)
  Evidence (5 events)

  • Aug 14, 2026 · SEC Form D 0002148840-26-000005
    Name of Issuer: MBQ PHARMA INC.; CIK: 2148840; Address: San Juan, PR; Submission type: D; Filing date: 2026-08-14; Industry Group: Pharmaceuticals; Date of First Sale: 2026-05-15; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 991038; Federal exemptions: 06b
  • Aug 14, 2026 · SEC Form D 0002148840-26-000004
    Name of Issuer: MBQ PHARMA INC.; CIK: 2148840; Address: San Juan, PR; Submission type: D; Filing date: 2026-08-14; Industry Group: Pharmaceuticals; Date of First Sale: 2023-08-24; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 500000; Total Amount Sold: 500000; Federal exemptions: 06b
  • Aug 14, 2026 · SEC Form D 0002148840-26-000003
    Name of Issuer: MBQ PHARMA INC.; CIK: 2148840; Address: San Juan, PR; Submission type: D; Filing date: 2026-08-14; Industry Group: Pharmaceuticals; Date of First Sale: 2022-03-30; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 325000; Total Amount Sold: 325000; Federal exemptions: 06b
  • Aug 14, 2026 · SEC Form D 0002148840-26-000002
    Name of Issuer: MBQ PHARMA INC.; CIK: 2148840; Address: San Juan, PR; Submission type: D; Filing date: 2026-08-14; Industry Group: Pharmaceuticals; Date of First Sale: 2021-02-01; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 882000; Total Amount Sold: 882000; Federal exemptions: 06b
  • Aug 14, 2026 · SEC Form D 0002148840-26-000001
    Name of Issuer: MBQ PHARMA INC.; CIK: 2148840; Address: San Juan, PR; Submission type: D; Filing date: 2026-08-14; Industry Group: Pharmaceuticals; Date of First Sale: 2018-06-30; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 1530000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals